NOTICE
The 11th U.S. - Japan Symposium on Drug Delivery Systems Began on Decemebr 16th

Abstract Submission Deadline Has Passed

The Next U.S. - Japan Symposium on Drug Delivery Systems will be held in December of 2013

10th US - Japan Symposium on Drug Delivery Systems

The 11th US-Japan Symposium on Drug Delivery Systems Conference is currently in session in Lahaina, Maui.

The Symposium is co-sponsored by the Japanese Society of Drug Delivery Systems, the Massachusetts Institute of Technology, and Kyoto University.

The symposium offers presentations by researchers from a number of disciplines, from the life sciences to engineering, who will address a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermals, pulmonary delivery, new materials, and other subjects, from varied disciplines while focusing on the central theme of drug delivery. The Symposium offers a unique opportunity for interaction and networking among attendees from academia and industry.

Agenda

FRIDAY, December 16, 2011

2:30-5:30 PM       Ocean Lanai Terrace     Registration
5:45–6:55 PM       Aloha Pavilion                Welcome Reception
Evening Plenary Session - 7:00 - 10:15 PM

SATURDAY, DECEMBER 17, 2011

7:00 - 8:00am      Ocean Lanai Terrace      Registration
MORNING PLENARY SESSION – 8:30 AM – 1:00 PM
Afternoon Unscheduled
EVENING PLENARY SESSION – 7:00 – 10:10 PM

SUNDAY, December 18, 2009

MORNING PLENARY SESSION 8:30 AM – 1:00 PM
Afternoon Unscheduled
EVENING SESSION – POSTER SESSION #1 - 7:30 – 10:00 PM
Oral Presentations - Selected from Poster Session #1

MONDAY, December 19, 2011

MORNING PLENARY SESSION - 8:30 AM – 1:00 PM
Afternoon Unscheduled
EVENING PLENARY SESSION – 7:00 – 10:00 PM


TUESDAY, December 20, 2011

MORNING PLENARY SESSION – 8:30 AM – 1:00 PM
Afternoon Unscheduled
EVENING SESSION – POSTER SESSION # 2 – 7:30 – 10:00 PM
Oral Presentations - Selected from Poster Session #2

Speakers

Khurseed Anwer  EGEN, Inc.
Sangeeta Bhatia MIT
Henry Brem Johns Hopkins 
Ron Demers Demers Consulting
Joseph DeSimone Univer. of North Carolina - Chapel Hill
Sarma Duddu TARIS Biomedical
Oliver Fetzer Cerulean Pharmaceuticals
Mitsuru Hashida Kyoto University 
Yuriko Higuchi Kyoto University 
Jeff Hrkach BIND Biosciences, Inc 
Noritaka Isogai Kinki University School of Medicine
Juichi Ito  Kyoto University 
Kiyokazu Iwata DDS Research Group 
Lloyd Johnston Selecta Biosciences, Inc. 
Yasufumi Kaneda Osaka University 
Joseph Kim   Inovio Biomedical Corp. 
Lothar Kleiner Abbot Vascular
Joachim Kohn New Jersey Center for Biomaterials
Satoru Konishi  Ritsumeikan University
Victor Kotelianski Alnylam Pharmaceuticals
Shoen Kume Kumamoto University
Cato T. Laurencin University of Connecticut
Doug Levinson Seventh Sense Biosystems
Chad Mirkin Northwestern University
Shinsaku Nakagawa Osaka University
Maria Palasis Arsenal Medical
John Patton Dance Pharmaceuticals
Francis Szoka University of California -San Francisco
Shunsaku Watanabe  Astellas Pharma Inc.
Ling Wong  Gates Foundation
Eiichi Yamamoto Eisai Product Creation Systems 
Kenji Yasuda  Tokyo Medical & Dental University
Chae-Ok Yung  Yonsei University College of Medicine
TBA Kala Pharmaceuticals 


To download the information brochure on The 11th US-Japan Symposium on Drug Delivery Systems Conference in PDF format right click here and select Save Target As.

*Drug delivery is a term that refers to the delivery of a pharmaceutical compound to humans or animals. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Many medications, however, can not be delivered using these routes because they might be susceptible to degradation or are not incorporated efficiently. For this reason many protein and peptide drugs have to be delivered by injection. For example, many immunizations are based on the delivery of protein drugs and are often done by injection.

Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues) and sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation.


*Source: Wikipedia

 

*Abstract
Abstract (summary), an abbreviated summary of any in-depth analysis of a particular subject or discipline.

 

*Source Wikipedia

 

Designed by V&V Design and Marketing